Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 12/2002

01-12-2002

Effect of Lafutidine, a Histamine H2-Receptor Antagonist, on Gastric Mucosal Blood Flow and Duodenal HCO3 − Secretion in Rats: Relation to Capsaicin-Sensitive Afferent Neurons

Authors: Hiroshi Mimaki, Shigeru Kagawa, Masako Aoi, Shinichi Kato, Tsutumi Satoshi, Kazuhiro Kohama, Koji Takeuchi

Published in: Digestive Diseases and Sciences | Issue 12/2002

Login to get access
Metadata
Title
Effect of Lafutidine, a Histamine H2-Receptor Antagonist, on Gastric Mucosal Blood Flow and Duodenal HCO3 − Secretion in Rats: Relation to Capsaicin-Sensitive Afferent Neurons
Authors
Hiroshi Mimaki
Shigeru Kagawa
Masako Aoi
Shinichi Kato
Tsutumi Satoshi
Kazuhiro Kohama
Koji Takeuchi
Publication date
01-12-2002
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 12/2002
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1021021625569

Other articles of this Issue 12/2002

Digestive Diseases and Sciences 12/2002 Go to the issue

OriginalPaper

Development of a Vitamin D-Responsive Organ Culture System for Adult and Old Rat Intestine

OriginalPaper

Can Quantitative Tests of Liver Function Discriminate Between Different Etiologies of Liver Cirrhosis?

OriginalPaper

Effects of Seirogan (Wood Creosote) on Propulsive Colonic Motility and Stool Characteristics in Ambulatory Mini-Pigs

OriginalPaper

Clinical Features of Patients with Novel Yersinia Species

OriginalPaper

Induction of a 72-kDa Heat-Shock Protein in Cultured Rat Gastric Mucosal Cells and Rat Gastric Mucosa by Zinc l-Carnosine

BriefCommunication

CASE REPORT: Fatal Spontaneous Gallbladder Variceal Bleeding in a Patient with Alcoholic Cirrhosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits